Latest biotechnology News | Page 3

Australia’s clinical trial sector connects at AusBiotech 2023
Grants to build Australia’s Quantum pipeline
AusBiotech energised by new Board appointments
BioNTech to establish clinical-scale mRNA manufacturing facility at La Trobe University
Leibniz Prizes for two Max Planck scientists
Cynata Therapeutics secures approval for Phase 2 trial in Turkey
Microba Life Sciences announces results of successful Phase IBD trial
Telix says the first patient dosed in European early access program for TLX250-CDx
Neuren Pharmaceuticals completes enrolment in Pitt Hopkins syndrome Phase 2 trial
Australia’s Cell and Gene Catalyst calls for Expressions of Interest
Appointments to Foreign Investment Review Board
OncoSil Medical onboards first patient in the PANCOSIL clinical trial
Korean regulator approves Amplia Therapeutics’ pancreatic cancer trial
Sugar permeation discovered in plant aquaporins
University of Manchester launches new strategic partnership with Osaka University
COP28: Roundtable highlights FAO-IAEA Joint Centre’s work on nuclear techniques in food and agriculture amid climate crisis
Clarity’s theranostic prostate cancer trial progresses at the highest dose level cohort
Microba completes stage one screening for its autoimmune disease program
National Reconstruction Fund (NRF) investment mandate released
Clairvoyant Surpasses 50 Per Cent Randomization in its Phase 2b Psilocybin Therapy Trial for Alcohol Use Disorder
University of Manchester, Boots and No7 beauty company secure multi-million-pound funding for inclusive dermatology research programme
Researchers advance ‘placenta-on-a-chip’ with sensing, imaging technology
Federal government backs the development of treatment for childhood brain cancer
Dimerix’s ACTION3 investigational new drug approved in China
Medical science a ‘priority area’ for new Industry Growth Program
AusBiotech weighs in on Australia’s RNA future
Oral delivery possibility for silica-based C’Dots
Broad Bean Thrives Despite Hyperactive Ion Channel
Drug resistance may make common infections like thrush untreatable
The Cell and Gene Catalyst call for change in submission to scope of practice review
Alterity Therapeutics raises $4.8 million in new placement
Orthocell announces final positive results of cell therapy in ‘tennis elbow’ study
Anteris reports positive 30-Day haemodynamic results from trial
Victoria’s Consular Corps visit Monash, scientists showcase latest innovations
UQ leads state at Life Sciences Queensland Awards
Biotech headed to Hill for AusBiotech’s Policy Forum
Alterity Therapeutics announces presentation of new data for ATH434
US FDA grants Argenica Therapeutics’ ARG-007 orphan drug designation
Neuren Pharmaceuticals completes Phelan-McDermid syndrome Phase 2 trial 
University of Queensland to establish world-leading mRNA laboratory
Telix says first patient dosed in ProstACT study of prostate cancer candidate
New report demonstrates benefit of long-term policy commitment
ARC Discovery project funding for geometry of the genome and the engineering of solid-state sodium batteries announced
HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director and CEO
New order for brewer’s yeast
Clarity says recruitment target achieved for Phase II SAR-Bombesin prostate cancer trial
Immutep announces the completion of key stage of AIPAC-003 trial in metastatic breast cancer
Cornell honored for work with international scholars